Investigating the effectiveness of Mediterranean diet on clinical symptoms and quality of life in patients with Behçet's disease

Effectiveness of Mediterranean diets compared with the regular pattern on clinical symptoms and quality of life in patients with Behçet's disease

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250125064513N1

Enrollment

Registered

2025-02-23

Start date

2025-02-28

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behcet's disease. Behcet's disease

Interventions

Intervention 1: Intervention group: They will receive a Mediterranean diet along with routine Behçet's treatments. Intervention 2: Control group: They will receive their usual diet along with routine

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients over 18 years of age with Behçet's disease

Exclusion criteria

Exclusion criteria: Unwillingness to participate in the study Malabsorption disorder Major gastrointestinal procedures Inability to swallow Comorbid underlying disease Pregnancy Use of anti-inflammatory or immunosuppressive drugs

Design outcomes

Primary

Measure	Time frame
Quality of life. Timepoint: Before the start of the intervention and 3 months after the intervention. Method of measurement: The SF-36 quality of life questionnaire will be used to assess quality of life before and 3 months after the intervention.;Clinical symptoms (oral, genital, skin, ocular, and joint lesions). Timepoint: Before the start of the intervention and 3 months after the intervention. Method of measurement: Clinical symptoms will be evaluated by the treating physician, ophthalmologist, and dermatologist, and imaging will be performed if necessary.	—

Measure

Time frame

Quality of life. Timepoint: Before the start of the intervention and 3 months after the intervention. Method of measurement: The SF-36 quality of life questionnaire will be used to assess quality of life before and 3 months after the intervention.;Clinical symptoms (oral, genital, skin, ocular, and joint lesions). Timepoint: Before the start of the intervention and 3 months after the intervention. Method of measurement: Clinical symptoms will be evaluated by the treating physician, ophthalmologist, and dermatologist, and imaging will be performed if necessary.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Hassani

Zanjan University of Medical Sciences

Fatemehh87@yahoo.com+98 24 3377 0804

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026